Weight loss clinic marketing: what GLP-1 program ads may say in 2026
By Erik Jia, founder of Oak Reel · Updated November 4, 2026
A weight loss clinic can advertise its program on Facebook and Instagram to adults, but naming semaglutide or tirzepatide makes it a prescription-drug ad, which Meta allows only for certified telehealth providers and pharmacies. Calling a compounded drug “the same as Ozempic” is a claim the FDA has cited sellers for. Leads in the nearest benchmarks cost about $27.11 to $32.14 (2026).
Paste your clinic’s website for three free sample video ads in its name and colours.
| Question | Short answer | Rule |
|---|---|---|
| Can a clinic name semaglutide or tirzepatide in a Meta ad? | Only as a certified telehealth provider or pharmacy with Meta’s written authorization | Meta Drugs and Pharmaceuticals policy |
| Can it say “same as Ozempic” or “generic Wegovy”? | No: the FDA lists that as false or misleading for compounded drugs | FDA guidance; warning letter, 2025-09-09 |
| Can the ad say “Struggling with your weight?” | No: it asserts the viewer’s health | Meta personal attributes |
| Are before-and-after photos allowed? | Meta allows them for adults; the FTC requires real patients and typical results | Meta Health and Wellness; 16 CFR 255.2(b) |
| Who can see weight loss ads? | People 18 and over | Meta Health and Wellness, age |
GLP-1 and weight loss advertising rules, quoted
Meta decides who may name the medicine; the FDA and FTC decide what any ad may claim. Each card quotes its source on the date it was read, and your state’s medical board and your counsel decide how they apply to your clinic.
Who may advertise the medicine
Meta
An ad that promotes semaglutide or tirzepatide needs LegitScript certification and Meta’s written permission first; telehealth programs and online pharmacies both need it.
“Meta requires online pharmacies and telehealth providers to be actively certified with LegitScript.”
Meta Advertising Standards: Drugs and Pharmaceuticals, certification, read 2026-11-04
Meta
A certified advertiser’s drug ad must also tell viewers to see a licensed professional or get a prescription, and may run only in the US, Canada or New Zealand, to adults.
“include a disclaimer to consult a licensed health professional or obtain a valid prescription”
Meta Advertising Standards: Drugs and Pharmaceuticals, disclaimer, read 2026-11-04
Meta
Education about prescription medicines needs no written permission. A physician explaining how this class of medicine works, without selling it, is the uncertified route; Meta decides what counts as selling.
“Educate, advocate or give public service announcements related to prescription drugs”
Meta Advertising Standards: Drugs and Pharmaceuticals, ads that need no written authorization, read 2026-11-04
Meta
A prescription weight-loss program answers to two Meta policies at once: the weight-loss rules below and the prescription drug rules above.
“For weight loss products that require prescription, please refer to Drugs and Pharmaceuticals ads policy”
Meta Advertising Standards: Health and Wellness, prescription weight loss, read 2026-11-04
What Meta rejects
Meta
Every weight-loss ad, with or without medication, is shown only to adults.
“must be targeted to people at least 18 years or older”
Meta Advertising Standards: Health and Wellness, age, read 2026-11-04
Meta
No hook may question or criticise the viewer’s body, so “Struggling with your weight?” and “Hate your stomach?” are out. Talk about the program, not the person watching.
“terms, descriptions, or questions that are negative and attack an individual's appearance, specific body parts, or hygiene”
Meta Advertising Standards: Health and Wellness, statements of inferiority, read 2026-11-04
Meta
“Lose 20 pounds in 8 weeks” is the shape Meta bans unless qualified; a number of pounds tied to a number of weeks needs a qualifier, and sensational wording is out entirely.
“promises of specific outcomes within a set timeframe without disclaimers or qualifiers”
Meta Advertising Standards: Health and Wellness, clickbait, read 2026-11-04
Compounded drugs and brand names
FDA
Calling a compounded medicine “generic Ozempic”, or the same as an approved drug, is a claim the FDA lists as false or misleading.
“describing a compounded drug as a generic version of an FDA-approved drug or the same as a drug approved by FDA”
FDA: what telehealth companies should know when promoting compounded drugs, read 2026-11-04
FDA
Compounded semaglutide or tirzepatide is never “FDA-approved”, and an ad may not suggest the FDA has checked it.
“the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed”
FDA: concerns with unapproved GLP-1 drugs used for weight loss, read 2026-11-04
FDA
Putting a brand name such as Mounjaro or Ozempic beside a compounded product implies sameness; the FDA cited exactly that in a 2025 warning letter.
“Your claims imply that your products are the same as an FDA-approved product when they are not.”
FDA warning letter to GLP-1 Solution, 2025-09-09, read 2026-11-04
Novo Nordisk
The brand names belong to the drugmakers, who have sued med spas and clinics over them. Name what the clinic offers in its own words.
“by enforcing our patents and trademarks and other laws whenever it is effective in mitigating illicit compounding.”
Novo Nordisk: our position on illicit compounding of semaglutide, read 2026-11-04
Results and photos
Meta
Meta does not ban showing results for adults; its allowed example shows a product’s impact and the time it took. The FTC rules below decide whether those results are honest.
“The ad can illustrate people using the product or the service, and its impact of using it”
Meta Advertising Standards: Health and Wellness, allowed weight-loss examples, read 2026-11-04
FTC
An average-loss figure needs records behind it. The FTC’s 2025 order against a GLP-1 telehealth firm followed claims of 53 pounds on average and photos of people who were never clients.
“requires competent and reliable evidence to support claims about the average or typical results users will achieve”
FTC press release on NextMed, 2025-07-14, read 2026-11-04
FTC
A real patient’s story still implies a typical result, so the ad must say what patients generally lose.
“should clearly and conspicuously disclose the generally expected performance in the depicted circumstances”
FTC Endorsement Guides, 16 CFR 255.2(b), read 2026-11-04
Prices
FTC
A monthly price that leaves out the medicine, labs or the visit is deceptive; the same FTC case charged it.
“without adequately disclosing that the price did not include the cost of the actual GLP-1 drug”
FTC press release on NextMed, 2025-07-14, pricing, read 2026-11-04
What changed, and what the marketing guides still get wrong
Oak Reel read 15 rules in 8 official texts on November 4, 2026. Much weight loss marketing advice still says Meta bans before-and-after photos. Its current health and wellness text does not: it allows ads shown to adults that depict a product’s impact. The limit on result photos now comes from the FTC, which requires the people shown to be real patients and the ad to say what patients generally achieve; in 2025 it charged a telehealth seller over before-and-after photos of people who were never its clients.
The ranking guides also skip the drug-name line. An ad about the clinic’s program, its clinicians and how follow-up works is a service ad; the same ad naming a GLP-1 is a prescription-drug ad with Meta’s certification rules attached.
What a weight loss lead costs on Facebook
No published benchmark separates weight loss clinics. The two nearest WordStream by LocaliQ medians for 2026:
- Health & Fitness
- $27.11 a lead
- Physicians & Surgeons
- $32.14 a lead
Median of US lead campaigns, WordStream by LocaliQ, 2026. Proxies, not weight loss figures; the editions move a lot (see the cost-per-lead page).
Programs are usually paid monthly, so the useful number is a patient’s first three months of fees against the ad cost of finding them. Put your own figures in the calculator.
Six weight loss clinic ad ideas that name no drug
Each comes from one 20 to 30-minute phone session with your physician or clinician, and each hook passes Oak Reel’s ad checker.
- 1
“What happens at a first medical weight-loss visit here”
The physician walks through the history, the weigh-in, which labs are drawn, and how the team decides whether medication is an option at all.
A process, with no question about the viewer’s body and no medicine named, so it does not promote a prescription drug.
- 2
“Approved or compounded: what the difference means”
The physician explains that FDA-approved medicines were reviewed before sale, compounded ones were not, and which kind the clinic prescribes.
Uses the FDA’s own distinction and avoids the sameness and generic claims the FDA lists as misleading.
- 3
“What our program fee covers, and what it does not”
The office manager says whether the medicine, labs, visits and follow-ups are in the monthly fee, and what is billed separately.
The FTC charged a GLP-1 program whose monthly price left out the drug and labs.
- 4
“The side effects we talk through at the first visit”
The physician names the common stomach side effects listed in the medicine’s label, how long they usually last, and when to call the clinic.
Names risks instead of downplaying them, and promises no result.
- 5
“Who is on our weight-loss care team”
The physician, the nurse and the dietitian each say their role and how often a patient sees them.
Leads with the clinicians, makes no outcome promise and never mentions the viewer’s weight.
- 6
“Why we check labs before prescribing any weight-loss medicine”
The physician explains which blood tests are ordered and why, and what results would change the plan.
Explains a medical step; the medicine stays unnamed, so the ad stays on the education side of Meta’s drug policy.
Ads that lead with your clinician
Oak Reel edits the footage into a month of Facebook and Instagram ads and runs them from your own ad account after you approve each one. The fee is $2,500 a month and does not change with the number of patients. The medical practice page covers a clinic’s other services.
Not a fit: telehealth sellers whose ads depend on naming the drug, or on photos of results. Those need certification and a compliance review of their own.
Make sample ads for my clinicQuestions weight loss clinics ask
- Can you advertise semaglutide on Facebook?
- Only a LegitScript-certified telehealth provider or online pharmacy, or a manufacturer through Meta’s review, with Meta’s written authorization, aimed at adults, with a disclaimer to consult a licensed professional. Ads that educate without promoting the drug need no authorization.
- Can I use the words Ozempic, Wegovy, Mounjaro or Zepbound?
- Their makers treat the names as trademarks to enforce, and naming a drug turns the ad into a prescription-drug ad on Meta. Oak Reel’s ads describe the program and the clinician, not the brand.
- Can a clinic still advertise compounded GLP-1s?
- Whether you may compound or prescribe them is a pharmacy and prescribing question for your counsel, not an ad rule. The FDA found both shortages resolved (tirzepatide 2024-12-19, semaglutide 2025-02-21), and it watches claims about compounded drugs on every platform.
- Do weight loss clinics make money from Facebook ads?
- Only if a patient’s first months of fees cover the ad cost of finding them. With leads at $27.11 to $32.14 in the nearest benchmarks, the program price and how many leads become patients decide it.
- What does LegitScript certification cost?
- LegitScript’s own fee list, read 2026-11-04, shows $975 per application and $2,150 a year. That is the clinic’s cost to become eligible to name the drug on Meta.